Bacteriostatic Water for GLP-1 Research Peptides: Selection and Reconstitution Protocol
Lyophilized semaglutide, tirzepatide, and retatrutide all reconstitute the same way in the lab: bacteriostatic water is the standard diluent. The 0.9% benzyl alcohol it carries acts as a preservative, holding sterility across repeated draws for 28 days under refrigeration at 2-8°C. That multi-draw window is the whole point. GLP-1 receptor agonist work also demands Type I borosilicate glass vials made under ISO 9001:2015 quality systems, each shipped with a per-lot Certificate of Analysis documenting USP <71> sterility assurance and pyrogen testing per USP <85> — the chain that keeps peptide stability and data integrity intact through long multi-dose protocols. For research-grade supply, see BAC Water Depot's 10 mL vial catalog.
Why GLP-1 Research Peptide Reconstitution Requires Bacteriostatic Water
GLP-1 receptor agonist peptides — semaglutide, tirzepatide, retatrutide — ship as lyophilized powders. They must be reconstituted before any laboratory use. The reason bacteriostatic water wins here comes straight from experimental design, which looks nothing like single-dose pharmaceutical dosing. A research protocol pulls multiple samples from one reconstituted vial across days or weeks. Every septum puncture adds contamination risk.
Bacteriostatic water carries 0.9% (9 mg/mL) benzyl alcohol, which suppresses bacterial growth in multi-dose containers per 21 CFR 610.15. That preservative action holds sterility for 28 days post-puncture at 2-8°C — long enough to cover the peptide research protocols built on serial dilutions, dose-response curves, and time-course experiments. The benzyl alcohol level is tuned to kill microbes without unfolding peptide secondary structure, which matters because GLP-1 agonist activity rides on intact alpha-helical domains.
Compare that to sterile water for injection. It carries no bacteriostatic agent and must be discarded the moment it is entered, under USP <797>. Water for Injection (WFI) gives you no multi-draw protection either. So for a lab running receptor binding assays, cell signaling studies, or pharmacokinetic modeling on GLP-1 peptides, a vial that can't be safely re-accessed wastes both bench time and money — and that money is real, given research-grade semaglutide runs $180-$320 per milligram and tirzepatide $210-$390 per milligram depending on supplier and purity grade.
The pH window helps too. Bacteriostatic water sits at 5.0-7.0 per USP monograph, comfortable territory for GLP-1 stability. Semaglutide holds its maximum conformational stability between pH 7.0-8.0 in phosphate buffers, yet it tolerates the mildly acidic bacteriostatic environment with no meaningful degradation across the 28-day use window. Teams working under institutional procurement protocols usually validate that compatibility by HPLC, confirming benzyl alcohol doesn't interfere with peptide detection or quantification.
Documentation closes the loop. Biomedical research compliance requires traceability from diluent all the way to the final result. BAC Water Depot supplies per-lot Certificates of Analysis covering sterility per USP <71>, bacterial endotoxin below 0.5 EU/mL per USP <85>, and pH verification — the paperwork a lab needs to keep 21 CFR Part 11 electronic records for FDA-auditable work. ISO 9001:2015 manufacturing keeps batches consistent, which is what makes dose preparation reproducible across a multi-year study.
Semaglutide Research Diluent: Vial Size and Volume Selection
Picking a vial size starts with arithmetic. Calculate total reconstituted volume from your target concentration, the number of planned sampling events, and dead volume in syringes and tubing. The 10 mL vial is the lab default for GLP-1 reconstitution — it swallows the usual lyophilized quantities of 2-10 mg and lands at working concentrations you actually use.
| Peptide Mass | Diluent Volume | Final Concentration | Typical Application | |--------------|----------------|---------------------|---------------------| | 2 mg semaglutide | 2 mL | 1.0 mg/mL | High-dose receptor saturation studies | | 5 mg tirzepatide | 5 mL | 1.0 mg/mL | Standard cell culture work (10-100 nM final) | | 5 mg retatrutide | 2 mL | 2.5 mg/mL | Stock solution for serial dilution | | 10 mg semaglutide | 10 mL | 1.0 mg/mL | Multi-week dosing regimen experiments |
Run the math on a typical dose-response design. Six-point concentration curves from 0.1 nM to 1 μM, with 5 mg peptide reconstituted in 5 mL, give you a 1.0 mg/mL stock. From that single vial, a researcher gets nine independent experiments across the 28-day window — each one drawing 50 μL for the dilution series plus 10% overage. That arithmetic is exactly why weight loss peptide research diluent selection drives both data quality and lab economics.
The 10 mL format from BAC Water Depot (CAT # BW-10, $9.99 single unit) uses Type I borosilicate glass meeting USP <660> for low extractables. That matters: silicate leaching can shift peptide ionization states during mass spectrometry. The 20 mm crimp-seal aluminum cap with a fluoropolymer-lined rubber stopper takes up to 40 needle punctures without core fragmentation, verified by USP <381> elastomeric closure integrity testing.
Evaporation is a quiet measurement problem. Sealed at 2-8°C, bacteriostatic water loses <0.3% volume over 28 days per USP stability protocols. Still, for work that needs ±2% concentration accuracy, verify volume with calibrated pipettes at days 0, 14, and 28. This is sharpest in tirzepatide reconstitution, where the dual GLP-1/GIP agonist activity produces steep dose-response curves — EC50 values for the two receptor subtypes differ by less than one order of magnitude.
Independent researchers handling smaller quantities of 0.5-2 mg can reconstitute in 2 mL inside a 10 mL vial, keeping headspace down to limit oxidative degradation. The larger container still buys easier needle access and less risk of puncture-through than a 2 mL or 5 mL vial. CRO laboratories running several peptides at once gain something else by standardizing on 10 mL: simpler inventory, lighter training load, and the freedom to dial reconstitution volume to each experiment.
Then there's temperature drift during access. Pull a vial from the fridge to sample and the solution warms roughly 1.2°C per minute at ambient 20-22°C. Keep room-temperature exposure under 5 minutes per access, and return the vial to 2-8°C the instant the needle clears the septum. The 10 mL thermal mass holds sub-10°C for about 3.8 minutes — a usable working window for aseptic technique that smaller volumes simply can't give you.
GLP-1 Agonist Lab Reconstitution: Step-by-Step Protocol
Technique shapes the data. How you reconstitute a GLP-1 peptide drives both reproducibility and recovery. The protocol below mirrors the workflows that academic and biotech startup laboratories run for receptor pharmacology on semaglutide, tirzepatide, and retatrutide.
-
Pre-reconstitution equilibration: Pull the lyophilized peptide vial and the bacteriostatic water from 2-8°C storage. Let both reach 15-20°C over 10-15 minutes — this prevents thermal shock and condensation. Check the lyophilized cake for collapse or discoloration, which flag manufacturing defects or shipping excursions. Confirm lot numbers and expiration dates against your records per the 21 CFR 809.10 documentation requirements for research materials.
-
Aseptic preparation: Work in an ISO Class 5 laminar flow hood or biosafety cabinet. Swab both septa with 70% isopropanol and give them 30 seconds to evaporate. Draw the calculated bacteriostatic water volume with a sterile 10 mL syringe and 18-gauge needle, holding slight negative pressure to keep aerosols from forming.
-
Controlled addition: Insert the needle through the peptide vial septum at a 45-degree angle so the bevel meets the inner wall. Run the bacteriostatic water slowly down that wall — never straight onto the cake, which triggers aggregation and foam. Aim for about 1 mL every 3-5 seconds on a 5 mg quantity. Gentle delivery protects the native conformation that GLP-1 receptor binding assays depend on.
-
Dissolution without agitation: Withdraw the needle and let the vial stand untouched for 3-5 minutes. GLP-1 agonist peptides usually dissolve in that span on their own. If particulates linger past 5 minutes, swirl gently in a circle. Do not shake or vortex — shear forces denature peptide bonds and throw off subvisible particles that light obscuration testing (USP <788>) will catch.
-
Clarity verification and documentation: Hold the solution against a white background under bright light. Correctly reconstituted semaglutide, tirzepatide, and retatrutide read clear to slightly opalescent, with no visible particulates. Record reconstitution date, time, lot numbers, final concentration, and technician initials on the label and in the notebook, per Good Laboratory Practice (GLP). Set the beyond-use date at 28 days from reconstitution, per USP <797> multi-dose container guidance for bacteriostatic water.
-
Storage and first-use verification: Return the vial to 2-8°C right away. For critical experiments, confirm concentration by UV spectroscopy (280 nm absorbance with peptide-specific extinction coefficients) or HPLC before you start. This check — especially valuable in university research laboratories training new staff — confirms full dissolution and catches formulation errors before any resources are committed.
Needle gauge changes the outcome. The 18-gauge needle above moves diluent fast but leaves wide punctures. If you plan 30+ accesses from one vial over 28 days, switch to 21-gauge or 23-gauge after the initial reconstitution. That cuts septum coring while still flowing fast enough for the sub-1 mL draws typical of GLP-1 receptor binding work.
One useful variation is the "wet-wall" technique. Add bacteriostatic water in 1 mL increments with 30-second pauses, letting the cake hydrate from the edge inward. It pays off most in tirzepatide reconstitution above 8 mg, where dumping diluent in fast creates local supersaturation and precipitation.
Which BAC Water Depot SKU fits this use case? Academic labs running 2-4 GLP-1 peptide reconstitutions monthly: 10-pack ($74.99 · $7.49/vial) CRO facilities with continuous peptide workflows: 25-pack ($174.99 · $6.99/vial) Institutional procurement programs requiring 50+ vials quarterly: Bulk program from $6.49/vial with consolidated shipping and standing purchase orders
28-Day Stability Under Refrigeration: Data Requirements for Retatrutide Research
Where does the 28-day number come from? USP <797> and USP <1176> set it for multi-dose containers. It's deliberately conservative, anchored to preservative efficacy testing under USP <51>, which demands that benzyl alcohol hold log-reduction of common contaminants — Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans — across 28 days at 2-8°C.
Two kinds of stability matter for GLP-1 work, and they pull apart. Microbiological stability is contamination control. Chemical stability is peptide integrity. Bacteriostatic water handles the first; the second rides on peptide-specific degradation. Semaglutide is well-behaved here — HPLC data show <3% degradation over 56 days in acetate buffer at pH 7.4 when reconstituted and held at 2-8°C. Its main breakdown product, desamido-semaglutide, forms via asparagine deamidation at position 34. That species keeps roughly 60% of wild-type GLP-1 receptor affinity, so it won't read as inert — it injects variability if you don't control for it.
Tirzepatide degrades faster, around 5-7% loss over 28 days at 2-8°C in phosphate buffer, driven mainly by methionine oxidation at position 14. Light and trace-metal contamination from glass container extractables speed it up, which is why Type I borosilicate is non-negotiable for long storage. Retatrutide research bacteriostatic water applications track similar stability profiles, though published data stay thin given how recently the peptide emerged.
For any GLP-1 work running past 14 days post-reconstitution, put these controls in place:
-
Concentration verification: Measure at days 0, 7, 14, 21, and 28 by UV absorbance or quantitative HPLC, calibrated with external standards across 0.1-2.0 mg/mL. Hold variance to ±5% of the day-0 baseline. Anything outside that retires the vial — regardless of the 28-day limit.
-
Visual inspection: Before every use, look for color change (yellowing flags oxidative degradation), turbidity (aggregation or precipitation), and particulates (protein aggregates or microbial growth). Any drift from initial clarity stops use immediately and triggers microbiological testing.
-
pH monitoring: Hydrolysis releases ammonia and organic acids, dropping solution pH. For critical work, confirm pH stays within ±0.3 units of the initial reading using micro-volume electrodes calibrated against NIST-traceable buffers at 4.00, 7.00, and 10.00.
-
Functional bioassays: Mechanistic studies should confirm retained activity in cell-based assays. For semaglutide and tirzepatide, that usually means cAMP accumulation in HEK293 cells expressing the human GLP-1 receptor, with EC50 values held within one standard deviation of historical controls. Potency loss above 15% signals chemical degradation — reconstitute fresh.
-
Sterility confirmation: High-risk applications such as veterinary research or work with immunocompromised animal models may call for terminal sterility testing at end-of-use, via USP <71> membrane filtration with 14-day incubation in thioglycollate and soybean-casein digest media. Bacteriostatic water should prevent growth; this verifies the aseptic technique behind it.
Temperature logging matters across the whole window. Continuous data loggers documenting 2-8°C give you objective proof the vial never broke stability limits. Even short jumps to 15-20°C — say, an extended session out of the fridge — push deamidation and oxidation along. Cap cumulative room-temperature exposure under 4 hours over the full 28 days.
One nuance worth stating plainly: the bacteriostatic water itself stays chemically stable well past 28 days. The USP limit is microbiological caution, not chemical decay. Even so, do not stretch the 28-day period for convenience. The research-use-only framework that governs this product holds you to pharmaceutical standards in non-clinical settings, and slipping past USP <797> erodes the rigor publishable research expects.
Certificate of Analysis Requirements: Documentation for Tirzepatide Research Reconstitution
The per-lot Certificate of Analysis (CoA) is your primary quality check when buying bacteriostatic water for GLP-1 work. A solid CoA documents the parameters below, each tested by accredited third-party labs operating under ISO/IEC 17025.
Sterility testing per USP <71>: Direct inoculation or membrane filtration, with 14-day incubation in fluid thioglycollate (aerobic and anaerobic bacteria) and soybean-casein digest medium (fungi). Results must show no microbial growth. The CoA should list incubation temperature (30-35°C for thioglycollate, 20-25°C for soybean-casein), duration, and a pass/fail call with technician signature and date.
Bacterial endotoxin testing per USP <85>: Limulus Amebocyte Lysate (LAL) kinetic chromogenic or kinetic turbidimetric assay. For bacteriostatic water the spec is typically ≤0.5 Endotoxin Units (EU) per mL — far under the 5.0 EU/mL ceiling for sterile water for injection. Insist on actual measured values, not just pass/fail. You need them to calculate endotoxin load in the final peptide solution, which matters for endotoxin-sensitive cell lines and receptor assays where LPS contamination scrambles signaling.
pH verification: Potentiometric measurement, NIST-traceable calibration at 25°C. Acceptable range is 5.0-7.0 per USP monograph. Batch-to-batch swing past 0.5 pH units points to process-control trouble. Labs running peptide research with pH-sensitive fluorescent probes or working near buffer-capacity limits should choose lots closest to their target — usually 6.5-7.0 for GLP-1 agonist work.
Benzyl alcohol content: HPLC with UV detection at 210 nm, or gas chromatography with flame ionization detection. Spec is 0.9% w/v ±10% (0.81-0.99%). Under-spec batches lack bacteriostatic protection; over-spec batches can precipitate peptide or cause solubility trouble with hydrophobic sequences. The measured percentage should appear on the CoA alongside the method reference and calibration-curve linearity.
Heavy metals screening: Inductively coupled plasma mass spectrometry (ICP-MS) for lead, arsenic, cadmium, and mercury. USP <232> sets limits of 5 μg/day for lead and arsenic, 2 μg/day for cadmium, and 1.5 μg/day for mercury based on parenteral dosing. Those limits target pharmaceutical products, but research-grade material should clear the same bar. For trace metal-sensitive experiments — metalloproteomics, metal-catalyzed oxidation — aim for CoA values below 0.1 ppb per species.
Particulate matter testing per USP <788>: Light obscuration or microscopic particle counting. Specifications require ≤25 particles ≥10 μm per mL and ≤3 particles ≥25 μm per mL for large-volume parenterals. Research-use bacteriostatic water isn't administered directly, but particulates are still a contamination risk and can nucleate peptide aggregation. The CoA should report actual counts at both size cutoffs, not a bare pass/fail.
BAC Water Depot ships per-lot CoAs covering every parameter above, tested by three independent third-party labs to confirm result concordance and remove single-lab bias. That triple-verification protocol — uncommon among research-grade suppliers — produces documentation fit for FDA-auditable work, grant applications with detailed methodology, and journals that require materials traceability.
Keep your CoA files organized by lot number and cross-referenced to experimental records. When you write up a GLP-1 study, the methods section should cite the bacteriostatic water lot and its key parameters: "Lyophilized semaglutide was reconstituted in bacteriostatic water (0.9% benzyl alcohol, USP grade, lot BW20260418, BAC Water Depot, City, State) with documented sterility per USP <71> and bacterial endotoxin content of 0.12 EU/mL per USP <85>."
Documentation at that level answers reviewer questions about materials quality, lets later researchers replicate the work, and shows the controls pharmacological research expects. The alternative is bleaner and riskier: bacteriostatic water with no CoA, bought from a general lab supplier, brings uncontrolled variables that can sink months of work if peptide stability or results get challenged later.
Institutional procurement teams vetting suppliers should treat CoA availability as non-negotiable. The price gap between documented research-grade bacteriostatic water ($7.49-$9.99 per 10 mL vial) and undocumented industrial alternatives ($3-5 per vial) is trivial next to one failed experiment or a rejected manuscript. Weigh a few more criteria too: CoA delivery timeline (ideally digital within 24 hours of shipment), document format (searchable PDF with lab accreditation certificates), and retention policy (minimum 5 years, matching most institutional record requirements).
Comparing Bacteriostatic Water to Alternative Diluents for GLP-1 Research
Newcomers to peptide reconstitution ask the obvious question: why bacteriostatic water and not sterile water, normal saline, DMSO, or a buffer? Each alternative carries its own trade-offs for GLP-1 agonist reconstitution.
Sterile Water for Injection (SWFI): No bacteriostatic agent, so it's single-use discard after the first puncture under USP <797>. Multi-sample workflows — the bread and butter of dose-response work — leave only two options with SWFI, both bad: reconstitute fresh peptide per experiment (brutal at $200-$400/mg) or re-enter a single-use vial and break sterility (unacceptable in regulated research). SWFI only wins when benzyl alcohol itself confounds the system — for instance, studying benzyl alcohol's own effects on cell membranes or GABA receptors, where even 0.01% residual skews the result.
0.9% Sodium Chloride (Normal Saline): Adds 154 mM NaCl that can shift peptide solubility and readouts. GLP-1 receptor activation drives intracellular calcium mobilization and sodium-dependent signaling, so exogenous chloride from saline can alter ionic driving forces and corrupt electrophysiology. Commercial saline also often hides preservatives (methylparaben, propylparaben) or buffers (acetate, citrate) — absent from the primary label, buried in the insert. Those undisclosed additives wreck reproducibility when lots from different manufacturers go in. Saline fits in vivo animal studies that need isotonicity. For in vitro receptor binding, signaling, or structural work, the minimal ionic content of bacteriostatic water is the better call.
Dimethyl Sulfoxide (DMSO): A staple for small-molecule libraries, wrong for peptides. Above 5%, DMSO unwinds secondary structure by weakening the hydrogen bonds that hold alpha-helices and beta-sheets together. Semaglutide's C-terminal alpha-helix (residues 13-35) anchors GLP-1 receptor binding; DMSO-driven unfolding drops affinity 10- to 100-fold depending on concentration and exposure. Its hygroscopic nature also muddies concentration measurement, and its 18.5°C freezing point solidifies it in refrigerated storage. The comparison between bacteriostatic water and DMSO lands firmly on aqueous diluents for preserving native conformation.
Acetic Acid Solutions: Pharmaceutical GLP-1 formulations use pH 7.4 phosphate buffer with acetic acid adjustment. Some researchers try to copy this by reconstituting in dilute acetic acid (0.1-1%). Acidic pH can lift solubility for peptides with high isoelectric points, but acetic acid solutions bring no bacteriostatic protection and add acetate counter-ions that may distort mass spectrometry ionization or enzyme kinetics. Unless the design specifically needs acetate conditions, bacteriostatic water keeps the composition simpler with fewer variables.
Phosphate-Buffered Saline (PBS): Defined pH (usually 7.4) and isotonic, but it loads in phosphate, sodium, potassium, and chloride. For cell culture where peptide is diluted 1:100 or more into media, PBS ionic content vanishes. For receptor binding on membrane preps or purified receptor, those same salts can shift Kd by reshaping the electrostatics in the binding pocket. Standard PBS also lacks preservatives; making it multi-dose means adding bacteriostatic agents (typically 0.05% sodium azide), which complicates the formulation and raises cytotoxicity flags for live-cell assays.
The table below summarizes key selection criteria:
| Diluent | Multi-Dose Use | Ionic Strength | pH Control | Peptide Compatibility | Cost per mL | |---------|----------------|----------------|------------|----------------------|-------------| | Bacteriostatic Water | 28 days | Minimal (hypotonic) | 5.0-7.0 | Excellent | $0.75-$1.00 | | Sterile Water (SWFI) | Single use only | Minimal | 5.0-7.0 | Excellent | $0.30-$0.50 | | Normal Saline | Requires preservative | 154 mM (isotonic) | 4.5-7.0 | Good | $0.40-$0.60 | | DMSO | Not recommended | N/A | N/A | Poor (denatures) | $1.20-$2.00 | | PBS pH 7.4 | Requires preservative | 150 mM (isotonic) | Buffered 7.4 | Good | $0.50-$0.80 |
Across the bulk of GLP-1 research — receptor binding, cell signaling, pharmacokinetics, structural biology — bacteriostatic water hits the best balance of sterility, chemical simplicity, peptide compatibility, and regulatory fit. The buying guide adds decision criteria for the specialized edge cases.
Common Mistakes to Avoid
-
Confusing research-grade with compounding-grade bacteriostatic water: Only USP-grade bacteriostatic water meeting current monograph specifications and accompanied by per-lot CoA documentation is appropriate for peptide research intended for publication or regulatory submission.
-
Exceeding the 28-day beyond-use date: Even if the solution appears clear and the peptide remains active, USP <797> compliance requires discarding reconstituted vials 28 days post-initial puncture to maintain sterility assurance and experimental rigor.
-
Storing bacteriostatic water at room temperature before use: Unopened vials should be stored at controlled room temperature per USP guidelines, but once a vial is opened (septum punctured), immediate refrigeration at 2-8°C is required to maintain the documented stability profile.
-
Using bacteriostatic water for neonatal or low-birth-weight animal studies: Benzyl alcohol toxicity in neonates is well-documented; research involving newborn or premature animal models requires preservative-free sterile water even if multi-dose convenience is sacrificed.
-
Assuming all bacteriostatic water is equivalent: Benzyl alcohol concentration, pH, particulate levels, endotoxin content, and container type vary significantly between manufacturers; consistency requires sourcing from a single qualified supplier with documented quality systems like ISO 9001:2015 certification.
-
Failing to document lot numbers in laboratory records: Without linking reconstitution events to specific bacteriostatic water lot numbers and corresponding CoAs, any anomalous experimental results become impossible to investigate or explain during manuscript review or regulatory audit.
-
Reconstituting directly into lyophilized peptide cake: Rapid injection onto the powder surface causes foaming, aggregation, and peptide loss adhered to foam bubbles; proper technique delivers diluent down the vial wall for gentle dissolution without mechanical stress.
-
Using expired bacteriostatic water beyond manufacturer dating: Expiration dates reflect guaranteed preservative efficacy and sterility assurance; expired lots may have reduced benzyl alcohol content or breached container integrity even if the solution appears normal.
People Also Ask
What concentration of benzyl alcohol is in bacteriostatic water for peptide research?
Bacteriostatic water contains 0.9% benzyl alcohol by volume (9 mg per mL), which is the USP monograph specification for multi-dose container preservation. This concentration provides bacteriostatic activity against common contaminants without denaturing peptide structure or interfering with most biological assays at typical dilution factors.
Can you use bacteriostatic water for semaglutide research if the peptide will be used the same day?
Yes, bacteriostatic water remains appropriate for same-day single-use applications and offers no disadvantage compared to sterile water for injection except marginally higher cost. For any protocol with repeated withdrawals over days, the benzyl alcohol preservative makes it the better choice; for a single same-day draw, either diluent works.
How long is reconstituted GLP-1 research peptide stable under refrigeration?
Reconstituted GLP-1 research solutions are commonly held for up to 28 days at 2–8°C, where the preservative suppresses microbial growth across repeated punctures. The peptide's own stability is the limiting factor, so confirm appearance is clear before each withdrawal and discard if anything looks off.
Can reconstituted GLP-1 peptide solutions be frozen for longer storage?
Repeated freeze-thaw cycles damage peptide structure and reduce recovery, so freezing the working vial is discouraged. If longer storage is required, aliquot into single-use portions before freezing and thaw only what each timepoint needs.
What should a Certificate of Analysis confirm for research bacteriostatic water?
A per-lot CoA should document sterility (USP <71>), endotoxin within specification, benzyl alcohol concentration, and pH for the exact lot shipped. Per-lot documentation reflects the material you actually receive rather than a generic product specification.
Why is gentle swirling preferred over shaking during reconstitution?
Shaking shears the peptide chain and whips air into the solution; the resulting foam concentrates peptide at the air-liquid interface where it denatures. Directing the water down the vial wall and swirling gently dissolves the cake without that mechanical stress.
About BAC Water Depot: Research-grade bacteriostatic water for qualified research institutions and laboratory buyers. ISO 9001:2015 registered US facility, verified by three independent testing laboratories, per-lot Certificate of Analysis. Same-day US shipping before 2pm ET. Card, Apple Pay, Venmo, and Zelle accepted — instructions arrive by email after checkout. Browse the catalog → · For research and laboratory use only — not for human or veterinary use.
Last reviewed: 2026-06-07